Multidrug-Resistant Escherichia coli Causing Urinary Tract Infections among Controlled and Uncontrolled Type 2 Diabetic Patients at Laquintinie Hospital in Douala, Cameroon

Table 3

Clinical features of the study participants.

Clinical symptoms		Nondiabetics; 346 (%)	Diabetics with balanced blood sugar levels; 226 (%)	Diabetics with unbalanced blood sugar; 279 (%)	χ ^2	Confidence interval ( value)
Asthenia	No	346 (100)	223 (98.67)	272 (97.49)	8.43	0.07–0.12 (<0.001)
	Yes	0 (00)	3 (1.33)	7 (2.51)
Vaginal itching	No	345 (99.71)	220 (97.35)	276 (98.92)	6.62	0.09–0.18 (0.036)
	Yes	1 (0.29)	6 (2.65)	3 (1.08)
Dysuria	No	346 (100)	204 (90.27)	260 (93.19)	31.84	0.31–0.60 (<0.001)
	Yes	0 (00)	22 (9.73)	19 (6.82)
Leukocyturia	No	335 (97.10)	184 (81.42)	201 (72.04)	77.33	1.04–1.32 (<0.001)
	Yes	10 (2.90)	42 (18.58)	78 (27.96)
Lack of appetite	No	346 (100)	226 (100)	278 (99.64)	2.05	0.58–0.68 (0.358)
	Yes	0 (00)	0 (00)	1 (0.36)
Diabetic wound	No	346 (100)	174 (76.99)	211 (75.63)	92.94	1.00–1.24 (<0.001)
	Yes	0 (00)	52 (23.01)	68 (24.37)
Polakiuria	No	346 (100)	225 (99.56)	279 (100)	2.76	0.25–0.27 (0.250)
	Yes	0 (00)	1 (0.44)	0 (00)
Polydipsia	No	346 (100)	224 (99.12)	277 (99.53)	2.82	0.22–0.24 (0.243)
	Yes	0 (00)	2 (0.88)	2 (0.72)
Polyphagia	No	346 (100)	216 (95.58)	256 (91.76)	28.40	0.26–0.35 (<0.001)
	Yes	0 (00)	10 (4.42)	23 (8.24)
Polyuria	No	343 (99.13)	150 (66.37)	144 (51.61)	197.05	0.34–0.36 (<0.001)
	Yes	3 (0.87)	76 (33.63)	135 (48.39)
Proteinuria	No	301 (86.99)	149 (65.93)	196 (70.25)	40.44	0.41–0.53 (<0.001)
	Yes	45 (13.01)	77 (34.07)	83 (29.75)